Doctors, psychologists, nurses and scientists specialized in mental health have come together to form the Spanish Society of Psychedelic Medicine (SEMPSI) in view of the progress in the studies of psychedelics as a therapy for mental pathologies and the paradigm shift they represent for the treatment of psychiatric illnesses.
The SEMPSi was established and approved its statutes last August and its management team has already requested its inclusion in the registry of associations of the Ministry of the Interior.
We want to establish guidelines based on scientific evidence for the application of these treatments
“The objective is to disseminate truthful information, based on scientific evidence, on the therapeutic use of psychedelics, and to establish clinical guidelines, codes of ethics and good practices for the application of these treatments in the health field”, explains its president, Óscar Soto Angona, who is an associate psychiatrist in the resistant depression program and a researcher at the Vall d’Hebron Hospital in Barcelona and has participated in various clinical trials with hallucinogens.
Together with Soto Angona, they make up the initial board of the Spanish Society of Psychedelic Medicine Óscar Álvarez (psychiatrist and researcher at the Parc Sanitari Sant Joan de Déu) as secretary; Santiago Madero (psychiatrist from the Clínic hospital) and Juan París (from the San Rafael hospital) as vice-presidents, and the researcher Antón Gómez-Escolar and the psychologist Iker Puente as members.
Although the activity of the SEMSi will be focused on the clinical use and research with psychedelics, Soto points out that they will also seek dialogue with the cultures and communities that have been using them for years in rituals and more traditional settings. “What we want is to bring all the existing scientific knowledge about psychedelics closer to both the medical field and the more popular one, seeking the clinical benefit of the public of both”, he points out.
Because, warn the promoters of the SEMPSi, psychedelics have been used non-medically for many years and the danger is that they are trivialized and false expectations are created about their effects in people who are having a hard time.
And they underline that, as is beginning to be seen in the United States, there is a risk that its popularization, added to certain business interests, ends up giving rise to phenomena of misuse and businesses that take advantage of the anguish and discomfort of people with mental health problems. to earn money without assessing whether the experience with these substances will help or harm those affected.